| HLA-DQB2 |
P05538
|
major histocompatibility complex, class II, DQ beta 2
|
Immune response
|
4.3E-02 |
0.573 |
0.731 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| HLA-G |
P17693
|
major histocompatibility complex, class I, G
|
|
1.4E-11 |
0.461 |
0.769 |
| HSPA1A |
P0DMV8 P0DMV9
|
heat shock protein family A (Hsp70) member 1A
|
|
3.0E-02 |
0.486 |
0.769 |
| HSPA1B |
P0DMV8 P0DMV9
|
heat shock protein family A (Hsp70) member 1B
|
|
5.3E-03 |
0.474 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| ICOS |
Q9Y6W8
|
inducible T cell costimulator
|
|
3.1E-02 |
0.502 |
0.731 |
| ICOSLG |
O75144
|
inducible T cell costimulator ligand
|
|
3.5E-04 |
0.601 |
0.654 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
| IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
| IL13 |
P35225
|
interleukin 13
|
|
1.4E-02 |
0.386 |
0.846 |
| IL15 |
P40933
|
interleukin 15
|
|
0.71 |
0.422 |
0.846 |
| IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
| IL17RA |
Q96F46
|
interleukin 17 receptor A
|
|
3.6E-04 |
0.529 |
0.808 |
| IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
| IL18R1 |
Q13478
|
interleukin 18 receptor 1
|
Receptor
|
8.6E-06 |
0.473 |
0.808 |
| IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |